Impact of Bionanointeractions of Engineered Nanoparticles for Nanomedicine

Nanotoxicology: Progress toward Nanomedicine

Volumn , Issue , 2014, Pages 21-35

  Sabella, Stefania ^a  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84927131157     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b16562-6     Document Type: Chapter

References (74)

1. Moghimi SM, Hunter AC, Murray JC. Nanomedicine: Current Status and Future Prospects. FASEB J 2005;19(3):311-30.
2. Blanco E, Hsiao A, Mann AP, Landry MG, Meric-Bernstam F, Ferrari M. Nanomedicine in Cancer Therapy: Innovative Trends and Prospects. Cancer Sci 2011;102(7):1247-52.
3. Brambilla D, Le Droumaguet B, Nicolas J, Hashemi SH, Wu LP, Moghimi SM, Couvreur P, Andrieux K. Nanotechnologies for Alzheimer’s Disease: Diagnosis, Therapy, and Safety Issues. Nanomedicine 2011;7(5):521-40.
4. Lobatto ME, Fuster V, Fayad ZA, Mulder WJ. Perspectives and Opportunities for Nanomedicine in the Management of Atherosclerosis. Nat Rev Drug Discov 2011;10(11):835-52.
5. Ding H, Wu F. Image Guided Biodistribution and Pharmacokinetic Studies of Theranostics. Theranostics 2012;2(11):1040-53.
6. Cingolani R, Athanassiou A, Pompa PP. Modulating Antibacterial Properties Using Nanotechnology. Nanomedicine (Lond) 2011;6(9):1483-5.
7. Rizzello L, Galeone A, Vecchio G, Brunetti V, Sabella S, Pompa PP. Molecular Response of Escherichia coli Adhering onto Nanoscale Topography. Nanoscale Res Lett 2012;7(1):575.
8. Kao J, Thorkelsson K, Bai P, Rancatore BJ, Xu T. Toward Functional Nanocomposites: Taking the Best of Nanoparticles, Polymers, and Small Molecules. Chem Soc Rev 2012;42(7):2654-78.
9. Talapin DV, Lee JS, Kovalenko MV, Shevchenko EV. Prospects of Colloidal Nanocrystals for Electronic and Optoelectronic Applications. Chem Rev 2010;110(1):389-458.
10. 2 Nanoparticles Biocompatibility and Their Potential for Gene Delivery and Silencing. Nanoscale 2012;4(2):486-95.
11. Li JF, Tian XD, Li SB, Anema JR, Yang ZL, Ding Y, Wu YF et al. Surface Analysis Using Shell-Isolated Nanoparticle-Enhanced Raman Spectroscopy. Nat Protoc 2013;8(1):52-65.
12. Petrova H, Perez-Juste J, Zhang Z, Zhang J, Kosel T, Hartland GV. Crystal Structure Dependence of the Elastic Constants of Gold Nanorods. J Mater Chem 2006;16(40):3957-63.
13. Maiorano G, Rizzello L, Malvindi MA, Shankar SS, Martiradonna L, Falqui A, Cingolani R, Pompa PP. Monodispersed and Size-Controlled Multibranched Gold Nanoparticles with Nanoscale Tuning of Surface Morphology. Nanoscale 2011;3(5):2227-32.
14. Schmidt U, Gunther C, Rudolph R, Bohm G. Protein and Peptide Delivery Via Engineered Polyomavirus-Like Particles. FASEB J 2001;15(9):1646-815.
15. Doshi N, Zahr AS, Bhaskar S, Lahann J, Mitragotri S. Red Blood Cell-Mimicking Synthetic Biomaterial Particles. Proc Natl Acad Sci USA 2009;106(51):21495-9.
16. Parak WJ. Materials Science. Complex Colloidal Assembly. Science 2011;334 (6061):1359-60.
17. Euliss LE, DuPont JA, Gratton S, DeSimone J. Imparting Size, Shape, and Composition Control of Materials for Nanomedicine. Chem Soc Rev 2006;35(11):1095-104.
18. Nel A, Xia T, Madler L, Li N. Toxic Potential of Materials at the Nanolevel. Science 2006;311(5761):622-7.
19. Montet X, Funovics M, Montet-Abou K, Weissleder R, Josephson L. Multivalent Effects of Rgd Peptides Obtained by Nanoparticle Display. J Med Chem 2006;49(20): 6087-93.
20. Nel AE, Madler L, Velegol D, Xia T, Hoek EM, Somasundaran P, Klaessig F, Castranova V, Thompson M. Understanding Biophysicochemical Interactions at the Nano-Bio Interface. Nat Mater 2009;8(7):543-57.
21. Lynch I, Salvati A, Dawson KA. Protein-Nanoparticle Interactions: What Does the Cell See? Nat Nanotechnol 2009;4(9):546-7.
22. Maiorano G, Sabella S, Sorce B, Brunetti V, Malvindi MA, Cingolani R, Pompa PP. Effects of Cell Culture Media on the Dynamic Formation of Protein-Nanoparticle Complexes and Influence on the Cellular Response. ACS Nano 2010;4(12):7481-91.
23. Sabella S, Maiorano G, Rizzello L, Kote S, Cingolani R, Pompa PP. Framing the Nano-Biointeractions by Proteomics. In Proc. SPIE 8232 2012;Colloidal Nanocrystals for Biomedical Applications VII, 82320S. San Francisco, CA, 2012.
24. Deng ZJ, Liang M, Monteiro M, Toth I, Minchin RF. Nanoparticle-Induced Unfolding of Fibrinogen Promotes Mac-1 Receptor Activation and Inflammation. Nat Nanotechnol 2011;6(1):39-44.
25. Mitragotri S, Lahann J. Physical Approaches to Biomaterial Design. Nat Mater 2009;8(1):15-23.
26. Rizzello L, Sorce B, Sabella S, Vecchio G, Galeone A, Brunetti V, Cingolani R, Pompa PP. Impact of Nanoscale Topography on Genomics and Proteomics of Adherent Bacteria. ACS Nano 2011;5(3):1865-76.
27. Brunetti V, Maiorano G, Rizzello L, Sorce B, Sabella S, Cingolani R, Pompa PP. Neurons Sense Nanoscale Roughness with Nanometer Sensitivity. Proc Natl Acad Sci USA 2010;107(14):6264-9.
28. Bayer IS, Fragouli D, Attanasio A, Sorce B, Bertoni G, Brescia R, Di Corato R et al. Water-Repellent Cellulose Fiber Networks with Multifunctional Properties. ACS Appl Mater Interfaces 2011;3(10):4024-31.
29. Rizzello L, Shankar SS, Fragouli D, Athanassiou A, Cingolani R, Pompa PP. Microscale Patterning of Hydrophobic/Hydrophilic Surfaces by Spatially Controlled Galvanic Displacement Reactions. Langmuir 2009;25(11):6019-23.
30. Rizzello L, Cingolani R, Pompa PP. Nanotechnology Tools for Antibacterial Materials. Nanomedicine (Lond) 2013;8(5):807-21.
31. Yoo JW, Irvine DJ, Discher DE, Mitragotri S. Bio-Inspired, Bioengineered and Biomimetic Drug Delivery Carriers. Nat Rev Drug Discov 2011;10(7):521-35.
32. Steichen SD, Caldorera-Moore M, Peppas NA. A Review of Current Nanoparticle and Targeting Moieties for the Delivery of Cancer Therapeutics. Eur J Pharm Sci 2012;48(3):416-27.
33. Fu D, Calvo JA, Samson LD. Balancing Repair and Tolerance of DNA Damage Caused by Alkylating Agents. Nat Rev Cancer 2012;12(2):104-20.
34. Ziegler CJ, Silverman AP, Lippard SJ. High-Throughput Synthesis and Screening of Platinum Drug Candidates. J Biol Inorg Chem 2000;5(6):774-83.
35. Gottesman MM, Fojo T, Bates SE. Multidrug Resistance in Cancer: Role of ATP-Dependent Transporters. Nat Rev Cancer 2002;2(1):48-58.
36. Allen TM. Ligand-Targeted Therapeutics in Anticancer Therapy. Nat Rev Cancer 2002;2(10):750-63.
37. Gao W, Liu W, Christensen T, Zalutsky MR, Chilkoti A. In Situ Growth of a Peg-Like Polymer from the C Terminus of an Intein Fusion Protein Improves Pharmacokinetics and Tumor Accumulation. Proc Natl Acad Sci USA 2010;107(38):16432-7.
38. Hubbell JA, Chilkoti A. Chemistry. Nanomaterials for Drug Delivery. Science 2012;337(6092):303-5.
39. Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008;7(9):771-82.
40. Duncan R. Polymer Conjugates as Anticancer Nanomedicines. Nat Rev Cancer 2006;6(9):688-701.
41. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an Emerging Platform for Cancer Therapy. Nat Nanotechnol 2007;2(12):751-60.
42. Webster DM, Sundaram P, Byrne ME. Injectable Nanomaterials for Drug Delivery: Carriers, Targeting Moieties, and Therapeutics. Eur J Pharm Biopharm 2013;84(1):1-20.
43. Matsumura Y, Maeda H. A New Concept for Macromolecular Therapeutics in Cancer Chemotherapy: Mechanism of Tumoritropic Accumulation of Proteins and the Antitumor Agent Smancs. Cancer Res 1986;46(12 Pt 1):6387-92.
44. Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles. Mol Pharm 2008;5(4):505-15.
45. Champion JA, Katare YK, Mitragotri S. Particle Shape: A New Design Parameter for Micro-and Nanoscale Drug Delivery Carriers. J Control Release 2007;121(1-2):3-9.
46. Sahay G, Alakhova DY, Kabanov AV. Endocytosis of Nanomedicines. J Control Release 2010;145(3):182-95.
47. Conner SD, Schmid SL. Regulated Portals of Entry into the Cell. Nature 2003;422(6927):37-44.
48. Service RF. Nanotechnology. Nanoparticle Trojan Horses Gallop from the Lab into the Clinic. Science 2010;330(6002):314-5.
49. Davis ME, Zuckerman JE, Choi CH, Seligson D, Tolcher A, Alabi CA, Yen Y, Heidel JD, Ribas A. Evidence of RNAi in Humans from Systemically Administered siRNA Via Targeted Nanoparticles. Nature 2010;464(7291):1067-70.
50. MacKay JA, Chen M, McDaniel JR, Liu W, Simnick AJ, Chilkoti A. Self-Assembling Chimeric Polypeptide-Doxorubicin Conjugate Nanoparticles That Abolish Tumours after a Single Injection. Nat Mater 2009;8(12):993-9.
51. Murakami M, Cabral H, Matsumoto Y, Wu S, Kano MR, Yamori T, Nishiyama N, Kataoka K. Improving Drug Potency and Efficacy by Nanocarrier-Mediated Subcellular Targeting. Sci Transl Med 2011;3(64):64ra2.
52. Park JH, Gu L, von Maltzahn G, Ruoslahti E, Bhatia SN, Sailor MJ. Biodegradable Luminescent Porous Silicon Nanoparticles for in vivo Applications. Nat Mater 2009;8(4):331-6.
53. Ashley CE, Carnes EC, Phillips GK, Padilla D, Durfee PN, Brown PA, Hanna TN et al. The Targeted Delivery of Multicomponent Cargos to Cancer Cells by Nanoporous Particle-Supported Lipid Bilayers. Nat Mater 2011;10(5):389-97.
54. Tang F, Li L, Chen D. Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery. Adv Mater 2012;24(12):1504-34.
55. von Maltzahn G, Park JH, Lin KY, Singh N, Schwoppe C, Mesters R, Berdel WE, Ruoslahti E, Sailor MJ, Bhatia SN. Nanoparticles That Communicate in vivo to Amplify Tumour Targeting. Nat Mater 2011;10(7):545-52.
56. Parodi A, Quattrocchi N, van de Ven AL, Chiappini C, Evangelopoulos M, Martinez JO, Brown BS et al. Synthetic Nanoparticles Functionalized with Biomimetic Leukocyte Membranes Possess Cell-Like Functions. Nat Nanotechnol 2013;8(1):61-8.
57. Merkel TJ, Jones SW, Herlihy KP, Kersey FR, Shields AR, Napier M, Luft JC et al. Using Mechanobiological Mimicry of Red Blood Cells to Extend Circulation Times of Hydrogel Microparticles. Proc Natl Acad Sci USA 2011;108(2):586-91.
58. Cumbo A, Lorber B, Corvini PF, Meier W, Shahgaldian P. A Synthetic Nanomaterial for Virus Recognition Produced by Surface Imprinting. Nat Commun 2013;4:1503.
59. Hu CM, Zhang L, Aryal S, Cheung C, Fang RH. Erythrocyte Membrane-Camouflaged Polymeric Nanoparticles as a Biomimetic Delivery Platform. Proc Natl Acad Sci USA 2011;108(27):10980-5.
60. Ng KK, Lovell JF, Zheng G. Lipoprotein-Inspired Nanoparticles for Cancer Theranostics. Acc Chem Res 2011;44(10):1105-13.
61. Cormode DP, Skajaa T, van Schooneveld MM, Koole R, Jarzyna P, Lobatto ME, Calcagno C et al. Nanocrystal Core High-Density Lipoproteins: A Multimodality Contrast Agent Platform. Nano Lett 2008;8(11):3715-23.
62. Skajaa T, Cormode DP, Jarzyna PA, Delshad A, Blachford C, Barazza A, Fisher EA, Gordon RE, Fayad ZA, Mulder WJ. The Biological Properties of Iron Oxide Core High-Density Lipoprotein in Experimental Atherosclerosis. Biomaterials 2011;32(1):206-13.
63. Luthi AJ, Zhang H, Kim D, Giljohann DA, Mirkin CA, Thaxton CS. Tailoring of Biomimetic High-Density Lipoprotein Nanostructures Changes Cholesterol Binding and Efflux. ACS Nano 2012;6(1):276-85.
64. McMahon KM, Mutharasan RK, Tripathy S, Veliceasa D, Bobeica M, Shumaker DK, Luthi AJ et al. Biomimetic High Density Lipoprotein Nanoparticles for Nucleic Acid Delivery. Nano Lett 2011;11(3):1208-14.
65. Wagner V, Dullaart A, Bock AK, Zweck A. The Emerging Nanomedicine Landscape. Nat Biotechnol 2006;24(10):1211-7.
66. Anon. Regulating Nanomedicine. Nat Mater 2007;6(4):249.
67. Vecchio G, Galeone A, Brunetti V, Maiorano G, Rizzello L, Sabella S, Cingolani R, Pompa PP. Mutagenic Effects of Gold Nanoparticles Induce Aberrant Phenotypes in Drosophila Melanogaster. Nanomedicine 2012;8(1):1-7.
68. Vecchio G, Galeone A, Brunetti V, Maiorano G, Sabella S, Cingolani R, Pompa PP. Concentration-Dependent, Size-Independent Toxicity of Citrate Capped AuNPs in Drosophila Melanogaster. PLoS One 2012;7(1):e29980.
69. Pompa PP, Vecchio G, Galeone A, Brunetti V, Maiorano G, Sabella S, Cingolani R. Physical Assessment of Toxicology at Nanoscale: Nano Dose-Metrics and Toxicity Factor. Nanoscale 2011;3(7):2889-97.
70. Sabella S, Brunetti V, Vecchio G, Galeone A, Maiorano G, Cingolani R, Pompa PP. Toxicity of Citrate-Capped AuNPs: An In Vitro and In Vivo Assessment. J Nanopart Res 2011;13(12):6821-35.
71. Brunetti V, Chibli H, Fiammengo R, Galeone A, Malvindi MA, Vecchio G, Cingolani R, Nadeau JL, Pompa PP. Inp/Zns as a Safer Alternative to Cdse/Zns Core/Shell Quantum Dots: In Vitro and In Vivo Toxicity Assessment. Nanoscale 2013;5(1):307-17.
72. Galeone A, Vecchio G, Malvindi MA, Brunetti V, Cingolani R, Pompa PP. In vivo Assessment of Cdse-Zns Quantum Dots: Coating Dependent Bioaccumulation and Genotoxicity. Nanoscale 2012;4(20):6401-7.
73. Pompa PP, Vecchio G, Galeone A, Brunetti V, Sabella S, Maiorano G, Falqui A, Bertoni G, Cingolani R. In vivo Toxicity Assessment of Gold Nanoparticles in Drosophila Melanogaster. Nano Research 2011;4(4):405-13.
74. Mahapatra I, Clark J, Dobson PJ, Owen R, Lead JR. Potential Environmental Implications of Nano-Enabled Medical Applications: Critical Review. Environ Sci: Proc and Impacts 2013;15(1):123-44.